{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:36:42Z","timestamp":1793378202378,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-13-20011"],"award-info":[{"award-number":["24-13-20011"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130333","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:16:26Z","timestamp":1752574586000},"page":"130333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Azolo[5\u2032,1\u2032,2,3]pyrimido[5,4-e]tetrazolo[1,5-c]pyrimidines as dual-action antiglycators and \u03b1-glucosidase inhibitors"],"prefix":"10.1016","volume":"128","author":[{"given":"Grigoriy V.","family":"Urakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin V.","family":"Savateev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel A.","family":"Slepukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir L.","family":"Rusinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umida M.","family":"Ibragimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman D.","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia I.","family":"Zhukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Sorokina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta R.","family":"Raiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman A.","family":"Litvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Spasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis A.","family":"Babkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bmcl.2025.130333_bb0005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/gerona\/glq074","article-title":"Does accumulation of advanced glycation end products contribute to the aging phenotype?","volume":"65A","author":"Semba","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130333_bb0010","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/nu2121247","article-title":"Dietary advanced glycation end products and aging","volume":"2","author":"Luevano-Contreras","year":"2010","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130333_bb0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbadis.2010.02.007","article-title":"Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis","volume":"1802","author":"Moheimani","year":"2010","journal-title":"BBA - Mol Basis Dis"},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2025.130333_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cca.2006.09.028","article-title":"Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance","volume":"377","author":"Gugliucci","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"Supplement_1","key":"10.1016\/j.bmcl.2025.130333_bb0025","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130333_bb0030","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jnr.21644","article-title":"Advanced glycation end products induce in vitro cross-linking of \u03b1-synuclein and accelerate the process of intracellular inclusion body formation","volume":"86","author":"Shaikh","year":"2008","journal-title":"J Neurosci Res"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130333_bb0035","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1007\/s13197-015-1851-y","article-title":"Advanced glycation End-products (AGEs): an emerging concern for processed food industries","volume":"52","author":"Sharma","year":"2015","journal-title":"J Food Sci Technol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130333_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/138945012799499758","article-title":"Advanced glycation end products as environmental risk factors for the development of type 1 diabetes","volume":"13","author":"Yap","year":"2012","journal-title":"CDT"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130333_bb0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00002281-200309000-00016","article-title":"AGEing and osteoarthritis: a different perspective","volume":"15","author":"Verzijl","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130333_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JAD-191236","article-title":"High dietary advanced glycation end products impair mitochondrial and cognitive function. Reddy PH, ed","volume":"76","author":"Akhter","year":"2020","journal-title":"JAD"},{"key":"10.1016\/j.bmcl.2025.130333_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2018.06.005","article-title":"Dietary advanced glycation end products and their relevance for human health","volume":"47","author":"Nowotny","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130333_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1940-6207.CAPR-19-0457","article-title":"Dietary advanced glycation end-products (AGE) and risk of breast cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO)","volume":"13","author":"Omofuma","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0070","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/j.clgc.2015.04.004","article-title":"Impact of oxidative stress biomarkers and carboxymethyllysine (an advanced glycation end product) on prostate cancer: a prospective study","volume":"13","author":"Yang","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.bmcl.2025.130333_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.662431","article-title":"Novo hepatocellular carcinoma in hepatitis C-related cirrhosis: are advanced glycation end products a key driver?","volume":"11","author":"Abdel-Razik","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130333_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2559.2007.02739.x","article-title":"Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma","volume":"51","author":"Sasahira","year":"2007","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbagen.2017.02.024","article-title":"Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression","volume":"1861","author":"Deng","year":"2017","journal-title":"BBA Gen Subj"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130333_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.abb.2003.08.009","article-title":"Novel inhibitors of advanced glycation endproducts","volume":"419","author":"Rahbar","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130333_bb0095","first-page":"204","article-title":"Evaluation in vitro of AGE-crosslinks breaking ability of rosmarinic acid","volume":"2","author":"Jean","year":"2015","journal-title":"Glycat Stress Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130333_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bmc.2014.12.003","article-title":"Fine tuning of 4,6-bisphenyl-2-(3-alkoxyanilino)pyrimidine focusing on the activity-sensitive aminoalkoxy moiety for a therapeutically useful inhibitor of receptor for advanced glycation end products (RAGE)","volume":"23","author":"Han","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130333_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-2952(00)00287-2","article-title":"Kinetics and mechanism of the reaction of aminoguanidine with the \u03b1-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions","volume":"60","author":"Thornalley","year":"2000","journal-title":"Biochem Pharmacol"},{"issue":"05","key":"10.1016\/j.bmcl.2025.130333_bb0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1371818","article-title":"Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes","volume":"122","author":"Kender","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0197-2456(99)00024-0","article-title":"Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II)","volume":"20","author":"Freedman","year":"1999","journal-title":"Contr Clin Trials"},{"key":"10.1016\/j.bmcl.2025.130333_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111750","article-title":"Novel advances in inhibiting advanced glycation end product formation using natural compounds","volume":"140","author":"Song","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/ijms18050984","article-title":"Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention","volume":"18","author":"Brings","year":"2017","journal-title":"IJMS"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130333_bb0130","doi-asserted-by":"crossref","DOI":"10.1070\/RCR5041","article-title":"Small synthetic molecules with antiglycation activity. Structure\u2013activity relationship","volume":"91","author":"Savateev","year":"2022","journal-title":"Russ Chem Rev"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130333_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700226","article-title":"6-Nitroazolo[1,5-a]pyrimidin-7(4H)-ones as antidiabetic agents","volume":"350","author":"Spasov","year":"2017","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2025.130333_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111808","article-title":"Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents","volume":"185","author":"Savateev","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"24","key":"10.1016\/j.bmcl.2025.130333_bb0145","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.3390\/molecules27248697","article-title":"6-(Tetrazol-5-yl)-7-aminoazolo[1,5-a]pyrimidines as novel potent CK2 inhibitors","volume":"27","author":"Urakov","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130333_bb0150","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/acs.orglett.0c03952","article-title":"Construction of bicyclic 1,2,3-triazine N-oxides from aminocyanides","volume":"23","author":"Liu","year":"2021","journal-title":"Org Lett"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130333_bb0155","first-page":"135","article-title":"Synthesis of new substituted 5,6-dihydrotetrazolo[1,5-c]quinazolines, tetrazolo[1,5-c]quinazolines, 5,6-dihydropyrimido[5,4-e]tetrazolo[1,5-c]pyrimidines, and 5,6-dihydrotetrazolo[1,5-c]pyrimidines","volume":"112","author":"Walter","year":"1988","journal-title":"Chemiker-Zeitung"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130333_bb0160","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s11164-013-1390-y","article-title":"Synthesis and antimicrobial studies of some novel series of fused naphthopyranotetrazole derivatives","volume":"41","author":"Kanakaraju","year":"2015","journal-title":"Res Chem Intermed"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130333_bb0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jhet.5570250247","article-title":"Synthesis of 5H-triazolo[1,5-d]- and 5H-tetrazolo-[1,5-d]thieno[3,2-f]-1,4-diazepin-6(7H)-ones","volume":"25","author":"Shishoo","year":"1988","journal-title":"J Heterocyclic Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130333_bb0170","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/jhet.2108","article-title":"Studies on synthesis of novel pyrido[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives and their antimicrobial activity","volume":"51","author":"Veeraswamy","year":"2014","journal-title":"J Heterocyclic Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130333_bb0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1134\/S0012500822600304","article-title":"A versatile method for the synthesis of 7-aminoazolo[1,5-a]pyrimidine-6-carbonitriles","volume":"505","author":"Urakov","year":"2022","journal-title":"Dokl Chem"},{"issue":"51","key":"10.1016\/j.bmcl.2025.130333_bb0180","doi-asserted-by":"crossref","first-page":"33406","DOI":"10.1021\/acsomega.0c05357","article-title":"2,6-Dicyano-4-pyrone as a novel and multifarious building block for the synthesis of 2,6-bis(hetaryl)-4-pyrones and 2,6-bis(hetaryl)-4-pyridinols","volume":"5","author":"Obydennov","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2025.130333_bb0185","series-title":"Nitrogen NMR","year":"1973"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130333_bb0190","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1016\/j.bmc.2008.04.002","article-title":"The pyridoxamine action on amadori compounds: a reexamination of its scavenging capacity and chelating effect","volume":"16","author":"Adrover","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130333_bb0195","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11030-024-10925-6","article-title":"Efficient synthesis and evaluation of therapeutic potential of fluorine containing 2-arylchromen-4-ones","volume":"29","author":"Troshkova","year":"2024","journal-title":"Mol Divers"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130333_bb0200","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/chem.201202154","article-title":"Tuning the nature of the fluorescent state: a substituted polycondensed dye as a case study","volume":"19","author":"Sissa","year":"2013","journal-title":"Chem Eur J"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130333_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/13880209.2015.1028080","article-title":"Antiglycation therapy: discovery of promising antiglycation agents for the management of diabetic complications","volume":"54","author":"Abbas","year":"2016","journal-title":"Pharm Biol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130333_bb0210","article-title":"Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Metabolic and Endocrine Disorders Group, ed","volume":"2018","author":"Moelands","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmcl.2025.130333_bb0215","article-title":"Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: design, synthesis, \u03b1-amylase, and \u03b1-glucosidase inhibitors with molecular docking simulation","volume":"275","author":"Khamees","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130333_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116595","article-title":"Novel thiosemicarbazide-based \u03b2-carboline derivatives as \u03b1-glucosidase inhibitors: synthesis and biological evaluation","volume":"275","author":"Liang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130333_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116434","article-title":"Probing benzenesulfonamide\u2013thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: \u03b1-glucosidase and carbonic anhydrase II","volume":"271","author":"Gamal","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130333_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138311","article-title":"Synthesis, anti-\u03b1-glucosidase activity, inhibition interaction, and anti-diabetic activity of novel cryptolepine derivatives","volume":"1310","author":"Feng","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2025.130333_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115957","article-title":"Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as \u03b1-glucosidase inhibitors with antidiabetic activity","volume":"264","author":"Hu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130333_bb0240","article-title":"Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as \u03b1-glucosidase inhibitors: insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties","volume":"269","author":"Khalili","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130333_bb0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40261-013-0063-3","article-title":"A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the GlucoVIP Study","volume":"33","author":"Zhang","year":"2013","journal-title":"Clin Drug Invest"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:20:59Z","timestamp":1776918059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S0960894X25002422"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130333","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azolo[5\u2032,1\u2032,2,3]pyrimido[5,4-e]tetrazolo[1,5-c]pyrimidines as dual-action antiglycators and \u03b1-glucosidase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130333"}}